Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
Эпигенетическая регуляция при метаболических заболеваниях: механизмы и достижения клинических исследований
2023-03-02
SCID: 54.1/ntyqkpfm
Discuss with AI
DNA methylationepigenetic biomarkersepigenetic regulationhistone modificationmetabolic diseases
Figures from the paper
Abstract (AI)
Epigenetics regulates gene expression and has been confirmed to play a critical role in a variety of metabolic diseases, such as diabetes, obesity, non-alcoholic fatty liver disease (NAFLD), osteoporosis, gout, hyperthyroidism, hypothyroidism and others. The term 'epigenetics' was firstly proposed in 1942 and with the development of technologies, the exploration of epigenetics has made great progresses. There are four main epigenetic mechanisms, including DNA methylation, histone modification, chromatin remodelling, and noncoding RNA (ncRNA), which exert different effects on metabolic diseases. Genetic and non-genetic factors, including ageing, diet, and exercise, interact with epigenetics and jointly affect the formation of a phenotype. Understanding epigenetics could be applied to diagnosing and treating metabolic diseases in the clinic, including epigenetic biomarkers, epigenetic drugs, and epigenetic editing. In this review, we introduce the brief history of epigenetics as well as the milestone events since the proposal of the term 'epigenetics'. Moreover, we summarise the research methods of epigenetics and introduce four main general mechanisms of epigenetic modulation. Furthermore, we summarise epigenetic mechanisms in metabolic diseases and introduce the interaction between epigenetics and genetic or non-genetic factors. Finally, we introduce the clinical trials and applications of epigenetics in metabolic diseases.
Key Findings
1
Epigenetic regulation is a critical contributor to diverse metabolic diseases, including diabetes, obesity, NAFLD, osteoporosis, gout, and thyroid disorders.
2
Epigenetic research supports clinical applications in metabolic diseases through biomarkers, epigenetic drugs, and epigenetic editing.
3
Four principal mechanisms—DNA methylation, histone modification, chromatin remodeling, and noncoding RNA—differentially influence metabolic disease development.
4
Genetic and non-genetic factors such as aging, diet, and exercise interact with epigenetic processes to shape disease-associated phenotypes.
5
The review synthesizes epigenetic research methods, disease mechanisms, factor interactions, and clinical trials and applications in metabolic disorders.
Research Object
Epigenetic mechanisms in metabolic diseases
Research Subject
the mechanisms, interactions with genetic and non-genetic factors, and clinical diagnostic and therapeutic applications of epigenetic regulation
Publication Details
Publication Date
2023-03-02
Journal
Publisher
ISSN
Cited by
507
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest